Morbidity and Mortality in Solo Adult Traumatic Brain Injury Patients in Minia University Hospital
Sponsor
Minia University (Other)
Overall Status
Completed
CT.gov ID
NCT05075239
Collaborator
(none)
62
1
4
15.5
Study Details
Study Description
Brief Summary
Tracking post-traumatic brain injury sequale
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
62 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Incidence Of Morbidity And Mortality After Isolated Traumatic Brain Injury In Adult Neuro-intensive Care Unit In Minia University Hospital
Actual Study Start Date
:
Sep 15, 2021
Actual Primary Completion Date
:
Jan 1, 2022
Actual Study Completion Date
:
Jan 15, 2022
Outcome Measures
Primary Outcome Measures
- mortality and morbidity [4 weeks]
number of deaths from neurotrauma
Secondary Outcome Measures
- prediction [one week]
to examine the predictors of outcome including age , gender , admission systolic blood pressure < 90 mmHg , GCS score ,APACHE II score ,lateralization of pupil , brain CT findings ,serum sodium &potassium ,mechanical ventilation and length of stay in ICU
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 65 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
- Solo non penetrating neurotrauma victims
Exclusion Criteria:
- 1- Penetrating head trauma. 2- Polytrauma patients. 3- Coexist of Psychiatric disorders or history of neuronal disorders. 4- Refusal of patient relatives to participate in the assignment. 5- Pregnant females with TBI. 6- Patients who died during 24 hours from admission to ICU . 7- Patients more than 65 years of age .
8- combined abdominal or orthopedic trauma.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Maher Maher | Minia | Egypt | 6115 |
Sponsors and Collaborators
- Minia University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Mina Maher,
Lecturer of anesthesia and ICU,
Minia University
ClinicalTrials.gov Identifier:
NCT05075239
Other Study ID Numbers:
- 411-9/2021
First Posted:
Oct 12, 2021
Last Update Posted:
Feb 4, 2022
Last Verified:
Feb 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mina Maher,
Lecturer of anesthesia and ICU,
Minia University
Additional relevant MeSH terms: